In large randomized controlled trials, patients receiving semaglutide 2.4 mg lost a mean of 6% of their weight by week 12 and 12% of their weight by week 28, Wissam Ghusn, MD, postdoctoral research fellow from the division of gastroenterology and hepatology of the Precision Medicine for Obesity Laboratory at Mayo Clinic in Rochester, Minnesota, and colleagues wrote
doi: 10.4110/in.2021.21.e3 236 SaadatM
But doctors have said that they are noticing an unusual thing in people on the medication, though unlike others this is not caused directly by the GLP-1 medication, but by the rapid weight loss it helps to bring about
hence GLP1-R signaling can contribute to the regulation of sodium balance and maintain blood pressure in the normal range ( Further experiments are still required to elucidate the potential mechanisms by which GLP1-R activation increases Treg functions ( However, the effects of GLP1-RAs on immune regulation still remain uncertain
Nutritional Improvement Correlates with Recovery of Activities of Daily Living among Malnourished Elderly Stroke Patients in the Convalescent Stage: A Cross-Sectional Study
Your provider at the Largo clinic will explain what to expect
